ANCOBON PRESCRIBING INFORMATION PDF

Package Insert-Flucytosine * Ancobon® is a The appropriate approved prescribing information should be consulted. Images. Group: antifungal. Capsule, mg [EDL] Solution for injection, g in ml [ EDL]. General information. Flucytosine is a fluorinated pyrimidine, non-antibiotic . Related Drug Information Flucytosine must be given with extreme caution to patients with bone marrow suppression. of America (IDSA) recommends 25 mg /kg/dose PO 4 times daily in combination with a lipid amphotericin B product.

Author: Fenrirn Tygokasa
Country: Algeria
Language: English (Spanish)
Genre: Art
Published (Last): 6 January 2004
Pages: 37
PDF File Size: 11.55 Mb
ePub File Size: 20.92 Mb
ISBN: 372-7-83398-713-2
Downloads: 7709
Price: Free* [*Free Regsitration Required]
Uploader: Akikus

Frequently monitor hepatic function during treatment with informatiom, as hepatotoxicity acute hepatic injury including hepatic necrosis, hepatic dysfunction, jaundice, and elevated hepatic enzymes has been reported with use.

Extend initial dosing interval to every 48 hours. Flucytosine is a fluorinated pyrimidine, non-antibiotic antifungal agent.

Find out more here. The risk or severity of adverse effects can be increased when Flucytosine is combined with Acteoside.

Flucytosine – DrugBank

Mizoribine The risk or severity of adverse effects can be increased when Flucytosine is combined with Mizoribine. Trichlormethiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is innformation with Flucytosine. The risk or severity of adverse effects can be increased when Flucytosine is combined with Voclosporin. Olaparib The risk or severity of adverse effects can be increased when Flucytosine is combined with Olaparib.

Vaccinia virus strain new york city board of health live antigen The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Flucytosine. If hypokalemia occurs or persists, consider reducing the dichlorphenamide dose or discontinuing dichlorphenamide therapy. The risk or severity of infection can be increased when BCG vaccine is combined with Flucytosine.

  GUIDO ARGENTINI SILVEREYE PDF

Flucytosine – Drugs Prescribing Information

The risk or severity of adverse effects can be increased when Bortezomib is combined with Flucytosine. Reviparin The risk or severity of bleeding can be increased when Reviparin is combined with Flucytosine. The risk or severity of adverse effects can be increased when Melphalan is combined with Flucytosine.

The risk or severity of neutropenia can be increased when Flucytosine is combined with Clozapine. Contraception in males and females: Palbociclib The risk or severity of adverse effects can be increased when Flucytosine is combined with Palbociclib. The risk or severity of ptescribing effects can be increased when Flucytosine is combined with Melengestrol.

Accumulation of flucytosine in amniotic fluid has been observed. Date of revision of the text.

Ancotil 2.5g/250ml Solution for Infusion

The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish live antigen is combined with Flucytosine. Cabazitaxel The risk or severity of adverse effects can be increased when Flucytosine is combined with Cabazitaxel. Antithrombin Alfa The risk or severity of bleeding can be increased when Antithrombin Alfa is infoemation with Flucytosine.

The therapeutic efficacy of Flucytosine can be decreased when used in combination with Cytarabine. The risk pfescribing severity of adverse effects can be increased when Flucytosine is combined with Lomustine.

The risk or severity of adverse effects can be increased when Flucytosine is combined with Carfilzomib. The risk or severity of adverse effects can be increased when Flucytosine is combined with Brequinar. The informtion efficacy of Tecemotide can be decreased when informatiion in combination with Flucytosine. The risk or severity of bleeding can be increased when Desmoteplase is combined with Flucytosine.

  BAHRU ZEWDE PDF

The risk or severity of adverse effects can be increased when Flucytosine is combined with Canakinumab. The risk or severity of bleeding can be increased when Sarpogrelate is combined with Flucytosine. Tedizolid phosphate The risk or severity of adverse effects can be increased when Flucytosine is combined with Tedizolid phosphate.

Flucytosine

To determine sensitivities, the methods of Shadomy Appl. Flucytosine is renally eliminated and must be given with extreme caution to patients with renal failure or renal impairment. Relcovaptan The risk or severity of bleeding can be increased when Relcovaptan is combined with Flucytosine. Treat for at least 4 to 6 weeks with final duration depending on resolution of lesions. Acetylsalicylic acid The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Flucytosine.

Flucytosine was not teratogenic in rabbits receiving doses of 0. Enteric bacteria may be responsible for some metabolism of flucytosine to 5-fluorouracil 5-FU. Trastuzumab The risk or severity of adverse effects can be increased when Trastuzumab is combined with Flucytosine.

How many drug targets are there? The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Flucytosine.